TLR4 and necrotizing enterocolitis: MSC secretome showed its efficiency in preventing and treating experimental NEC in mice and piglets by inhibiting TLR-4 signaling, reducing inflammation, and promoting intestinal remodeling and immune function, as shown by RNA sequencing (217).